NCT01934686
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Jakarta, Indonesia
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
7,980 public trials
715 recruiting studies
Diabetes Mellitus, Type 2 trial results
Completed
Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System
NCT02073058
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +8 more
- Locations
-
- AMCR Institute Escondido, California, United States
- Diablo Clinical Research Walnut Creek, California, United States
- Atlanta Diabetes Associates Atlanta, Georgia, United States
- Rainier Clinical Research Center Renton, Washington, United States
NCT00256633
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Carl T. Hayden VA Medical Center Phoenix, Arizona, United States
- Southern Arizona VA Health Care System, Tucson Tucson, Arizona, United States
- VA Central California Health Care System, Fresno Fresno, California, United States
- VA San Diego Healthcare System, San Diego San Diego, California, United States
NCT00256646
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Carl T. Hayden VA Medical Center Phoenix, Arizona, United States
- Southern Arizona VA Health Care System, Tucson Tucson, Arizona, United States
- VA Central California Health Care System, Fresno Fresno, California, United States
- VA Medical Center, Long Beach Long Beach, California, United States
NCT01572649
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Investigational Site Number 840005 Chula Vista, California, United States
- Investigational Site Number 840001 Overland Park, Kansas, United States
- Investigational Site Number 840003 Louisville, Kentucky, United States
- Investigational Site Number 484001 Puebla City, Mexico
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Fort Myers, Florida, United States
- San Antonio, Texas, United States
NCT00784745
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +7 more
- Locations
-
- Bispebjerg Hospital Copenhagen, Denmark
NCT00800683
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- 1218.43.10027 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
- 1218.43.10011 Boehringer Ingelheim Investigational Site Chula Vista, California, United States
- 1218.43.10006 Boehringer Ingelheim Investigational Site Riverside, California, United States
- 1218.43.10021 Boehringer Ingelheim Investigational Site Whittier, California, United States
Completed
Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes
NCT01512979
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- 1218.83.11002 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
- 1218.83.11036 Boehringer Ingelheim Investigational Site Little Rock, Arkansas, United States
- 1218.83.11011 Boehringer Ingelheim Investigational Site Chino, California, United States
- 1218.83.11001 Boehringer Ingelheim Investigational Site Huntington Beach, California, United States
NCT01906086
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Isfahan University of Medical Sciences Isfahan, Iran